Get started
APPLIED DNA SCIENCES INCAPPLIED DNA SCIENCES INCAPPLIED DNA SCIENCES INC

APPLIED DNA SCIENCES INC

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast

UDJ chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪378.50 K‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−15.95EUR
Net income (FY)
‪−9.41 M‬EUR
Revenue (FY)
‪12.65 M‬EUR
Shares float
‪880.17 K‬
Beta (1Y)
0.71

About Applied DNA Sciences, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
James A. Hayward
Website
adnas.com
Headquarters
Stony Brook
Employees (FY)
55
Founded
1983
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of UDJ is 0.41 EUR — it hasn't changed in the past 24 hours. Watch APPLIED DNA SCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange APPLIED DNA SCIENCES INC stocks are traded under the ticker UDJ.
UDJ stock has risen by 3.50% compared to the previous week, the month change is a 18.82% fall, over the last year APPLIED DNA SCIENCES INC has showed a 88.38% decrease.
We've gathered analysts' opinions on APPLIED DNA SCIENCES INC future price: according to them, UDJ price has a max estimate of 1.39 EUR and a min estimate of 1.39 EUR. Watch UDJ chart and read a more detailed APPLIED DNA SCIENCES INC stock forecast: see what analysts think of APPLIED DNA SCIENCES INC and suggest that you do with its stocks.
UDJ reached its all-time high on May 3, 2024 with the price of 3.96 EUR, and its all-time low was 0.33 EUR and was reached on Jun 21, 2024. View more price dynamics on UDJ chart.
See other stocks reaching their highest and lowest prices.
UDJ stock is 2.42% volatile and has beta coefficient of 0.71. Track APPLIED DNA SCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is APPLIED DNA SCIENCES INC there?
Today APPLIED DNA SCIENCES INC has the market capitalization of ‪378.50 K‬, it has increased by 2.49% over the last week.
Yes, you can track APPLIED DNA SCIENCES INC financials in yearly and quarterly reports right on TradingView.
APPLIED DNA SCIENCES INC is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
UDJ earnings for the last quarter are −4.92 EUR per share, whereas the estimation was −4.17 EUR resulting in a −18.00% surprise. The estimated earnings for the next quarter are −0.46 EUR per share. See more details about APPLIED DNA SCIENCES INC earnings.
APPLIED DNA SCIENCES INC revenue for the last quarter amounts to ‪861.57 K‬ EUR, despite the estimated figure of ‪881.37 K‬ EUR. In the next quarter, revenue is expected to reach ‪1.03 M‬ EUR.
UDJ net income for the last quarter is ‪−4.14 M‬ EUR, while the quarter before that showed ‪−1.00 M‬ EUR of net income which accounts for −313.81% change. Track more APPLIED DNA SCIENCES INC financial stats to get the full picture.
No, UDJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 29, 2024, the company has 55.00 employees. See our rating of the largest employees — is APPLIED DNA SCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APPLIED DNA SCIENCES INC EBITDA is ‪−12.30 M‬ EUR, and current EBITDA margin is −71.75%. See more stats in APPLIED DNA SCIENCES INC financial statements.
Like other stocks, UDJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APPLIED DNA SCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.